vs
Side-by-side financial comparison of VAALCO ENERGY INC (EGY) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
VAALCO ENERGY INC is the larger business by last-quarter revenue ($91.0M vs $70.6M, roughly 1.3× Viridian Therapeutics, Inc.\DE). Viridian Therapeutics, Inc.\DE runs the higher net margin — -49.0% vs -64.4%, a 15.3% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -25.2%).
VAALCO Energy is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Houston, Texas with operations primarily in the Etame Marin block offshore Gabon.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
EGY vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $91.0M | $70.6M |
| Net Profit | $-58.6M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | -71.3% | -56.7% |
| Net Margin | -64.4% | -49.0% |
| Revenue YoY | -25.2% | 81958.1% |
| Net Profit YoY | -602.5% | 54.9% |
| EPS (diluted) | $-0.56 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $91.0M | — | ||
| Q3 25 | $61.0M | $70.6M | ||
| Q2 25 | $96.9M | — | ||
| Q1 25 | $110.3M | — | ||
| Q4 24 | $121.7M | — | ||
| Q3 24 | $140.3M | — | ||
| Q2 24 | $116.8M | — | ||
| Q1 24 | $100.2M | — |
| Q4 25 | $-58.6M | — | ||
| Q3 25 | $1.1M | $-34.6M | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $7.7M | — | ||
| Q4 24 | $11.7M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $28.2M | — | ||
| Q1 24 | $7.7M | — |
| Q4 25 | -71.3% | — | ||
| Q3 25 | 1.5% | -56.7% | ||
| Q2 25 | 17.7% | — | ||
| Q1 25 | 23.7% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 31.4% | — | ||
| Q2 24 | 17.5% | — | ||
| Q1 24 | 32.1% | — |
| Q4 25 | -64.4% | — | ||
| Q3 25 | 1.8% | -49.0% | ||
| Q2 25 | 8.6% | — | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 9.6% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 24.1% | — | ||
| Q1 24 | 7.7% | — |
| Q4 25 | $-0.56 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.08 | — | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $0.12 | — | ||
| Q3 24 | $0.10 | — | ||
| Q2 24 | $0.27 | — | ||
| Q1 24 | $0.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.9M | $490.9M |
| Total DebtLower is stronger | $60.0M | — |
| Stockholders' EquityBook value | $443.5M | $503.0M |
| Total Assets | $913.4M | $577.1M |
| Debt / EquityLower = less leverage | 0.14× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $58.9M | — | ||
| Q3 25 | $24.0M | $490.9M | ||
| Q2 25 | $67.9M | — | ||
| Q1 25 | $40.9M | — | ||
| Q4 24 | $82.7M | — | ||
| Q3 24 | $89.1M | — | ||
| Q2 24 | $62.9M | — | ||
| Q1 24 | $113.3M | — |
| Q4 25 | $60.0M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $60.0M | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
| Q4 25 | $443.5M | — | ||
| Q3 25 | $505.9M | $503.0M | ||
| Q2 25 | $511.6M | — | ||
| Q1 25 | $504.1M | — | ||
| Q4 24 | $501.6M | — | ||
| Q3 24 | $501.0M | — | ||
| Q2 24 | $493.6M | — | ||
| Q1 24 | $472.6M | — |
| Q4 25 | $913.4M | — | ||
| Q3 25 | $950.4M | $577.1M | ||
| Q2 25 | $964.9M | — | ||
| Q1 25 | $927.1M | — | ||
| Q4 24 | $955.0M | — | ||
| Q3 24 | $937.9M | — | ||
| Q2 24 | $917.4M | — | ||
| Q1 24 | $809.1M | — |
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $145.2M | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $145.2M | — | ||
| Q3 25 | $16.4M | $-84.6M | ||
| Q2 25 | $18.3M | — | ||
| Q1 25 | $32.7M | — | ||
| Q4 24 | $44.5M | — | ||
| Q3 24 | $47.8M | — | ||
| Q2 24 | $-438.0K | — | ||
| Q1 24 | $21.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $-84.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | $29.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -120.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | 26.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 14.94× | — | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 4.23× | — | ||
| Q4 24 | 3.82× | — | ||
| Q3 24 | 4.35× | — | ||
| Q2 24 | -0.02× | — | ||
| Q1 24 | 2.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGY
| Crude Oil Sales And Purchase Agreements | $54.8M | 60% |
| Other | $31.9M | 35% |
| Crude Oil | $3.0M | 3% |
| Natural Gas Liquids Reserves | $1.4M | 2% |
VRDN
Segment breakdown not available.
